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ABSTRACT 
Objective: Structural elucidation studies on Trichosanthes lobata ethyl acetate and methanol extracts of leaf and stem parts through Gas 
Chromatography-Mass Spectrometry (GC-MS) technique with respect to anti-inflammatory potential.  
Methods: Extracts obtained with shade dried and powdered samples in successive solvent extraction using ethyl acetate and methanol by Soxhlet 
apparatus and subjected to GC-MS analysis and interpreted for its anti-inflammatory compounds.  
Results: The study revealed that the extraction solvent used was able to recover compound of classes such as organic acid esters and conjugated 
alkaloids in larger quantities than other classes of compounds and they varied with leaf and stem and also with the polarity of solvents used. In total 
compounds identified, GC-MS profile of the Ethyl Acetate leaf extract of T. lobata contained 41 compounds, stem extract contained 45 compounds 
which have reported bioassays in PubChem. Whereas GC-MS profile of methanol leaf extract of T. lobata contained 66 compounds and stem extract 
contained 46 compounds having bioassay reports in PubChem. A large number of phytochemical peaks with good area percentage were found in 
methanolic extract. We were also able to find out potent anti-inflammatory compounds including Octanoic acid, Dodecanoic acid, Octadecane, Enoic 
acid, Hexanoic acid, Quinazolin-8-one, Ilicic acid, Pentadecanoic acid, Oxaspiro, Benzeneacetic acid, etc. from the extracts.  
Conclusion: T. lobata contains phytocompounds against inflammation which may serve as a new drug lead of natural products origin in future and 
make it employable in modern pharmacological practices. 
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INTRODUCTION 
Basically, nature is the first source of medicinal compounds, from 
which bigger and accurate molecules are being formed. Since ancient 
times the natural substrates have been used as a source of various 
products applied in food, drug, cosmetic, textile and energy [1]. These 
naturally available products of higher plants serve as traditional 
medicine, possibly due to scientifically not proven mechanisms of 
action. The natural compounds exhibit various beneficial biological 
activities such as antimicrobial, antioxidant, anticancer, anti-
inflammatory, anti-obesity, anti-angiogenic, neuroprotective activities, 
etc. Therefore, various phytochemicals isolated from plant sources 
have attracted much attention in the field of pharmacology [2]. 
Trichosanthes species belongs to Cucurbitaceae family. Generally, 
fruits of this species are proved to have good sources of phenolics and 
antioxidants, also possesses anticancer, antiproliferative, 
cardioprotective, antioxidant properties, etc. Many research studies 
have reported that it contains important protein called Ribosome 
Inactivating Protein which helps in the formulation of anticancer 
agents. In general, biological components present in plants are 
considered as a stimulant for its medical properties like anti-
inflammatory, antidiabetic, antiulcer and cardioprotective activities. 
Similarly, there are various herbal preparations from Trichosanthes 
species being prescribed widely for the treatment of inflammatory 
conditions. One such plant is Trichosanthes lobata Roxb. Commonly 
called as patolam, kaypanpatolam, kattupatolam and peppatolam. It is 
a monoecious climber, an indigenous species therapeutically used in 
the tribes of Idukki hills, Kerala, India. These species have shown the 
presence of active constituents like flavonoids, phenolics, carotenoids, 
saponins, triterpenoids, etc. Although the extracts of this plant have 
been traditionally used in the treatment of inflammations, there is no 
scientific evidence which supports this therapeutic use. Our earlier 
research has documented its acute and chronic in vivo anti-
inflammatory activities. The overall results obtained confirmed that 
the extracts of Trichosanthes lobata contain anti-inflammatory 
substances. 
Inflammation refers to the reaction of living tissues to overcome 
injury, infection or irritation. Lysosomal enzymes are released during 
inflammation producing a variety of disorders leading to tissue injury 
by damaging the macromolecules and lipid peroxidation of 
membranes. These activities are presumed to be responsible for 
certain pathological conditions such as heart attacks, septic shocks, 
rheumatoid arthritis, etc. The extracellular activity of these enzymes is 
said to be related to acute or chronic inflammation [3]. Thus, there is a 
need for natural anti-inflammatory agents to achieve increased 
pharmacological response and less side effects. In this regard, 
complementary, alternative and traditional medicine play a pivotal 
role in medication. While proving them through scientific methods 
gives more authentication to the practices followed. Fulzule et al. [4] 
studied anti-inflammatory activity of Trichosanthes cucumerina and it 
was evaluated by use of the carrageenan-induced paw edema model in 
Wistar rats. Also, the underlying mechanism by which T. cucumerina 
mediates the anti-inflammatory activity was assessed by determining 
its effects on membrane stabilizing activity and nitric oxide inhibitory 
activity. Inhibitions of nitric oxide (NO) production and membrane 
stabilization activities are probably the mechanisms by which ligand 
molecules mediate its anti-inflammatory actions. Those findings 
rationalized the traditional practice of this plant as an anti-
inflammatory agent. They suspect that membrane stabilizing abilities 
and the absence of inhibitory action are possible mechanisms through 
which T. cucumerina arbitrates its anti-inflammatory action. 
In this study, we have analysed the chemical profiling of ethyl acetate 
and methanol leaf and stem extracts of T. lobata, with special reference 
to their anti-inflammatory effects using by Gas Chromatography-Mass 
Spectrometry (GC-MS). The obtained compounds were checked for its 
anti-inflammatory properties in PubChem and tried to report the 
possible effect of plant extracts against inflammation. 
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MATERIALS AND METHODS  
Plant collection and preparation of plant extracts 
Fresh, healthy and matured leaves and stem of Trichosanthes lobata 
Roxb. were collected from Vattavada Panchayat (10 °10ʹ38.7ʺN 77 
°15ʹ33.ʺE), Koviloor Post, Idukki District, Kerala state of India. The 
authenticity of the selected plant species was confirmed from the 
Botanical Survey of India, Southern Circle, Coimbatore (Vide No: 
BSI/SRC/5/23/2016/Tech./213). The leaves and stem were cleaned, 
dried in shade and ground well to a fine powder. About 50 g of dry 
powders were subjected to successive solvent extraction with ethyl 
acetate and methanol using Soxhlet apparatus. The filtered and dried 
extracts were subjected for GC-MS analysis. 
Gas chromatography-mass spectrometry (GC-MS) analysis  
The GC-MS analysis was carried out using the instrument Thermo 
GC-Trace Ultra Ver: 5.0, Thermo MS DSQ II with Column: DB 35-MS 
Capillary Standard Non-Polar Column possessing Dimension: 30 
Mts, ID: 0.25 mm, Film: 0.25 μm. The initial temperature of the 
instrument was set to 110 °C and maintained for 2 min. At the end of 
this period, the oven temperature was raised up to 260 °C, at the 
rate of an increase of 6 °C/min, and maintained for 9 min. The 
temperature of injection port was ensured as 250 °C and the flow 
rate of Helium as 1 ml/min. An injection volume of 1 µl of sample is 
considered in the analysis. The ionization voltage was maintained to 
be 70 eV and samples were injected in split mode in the ratio 10:1. 
Mass Spectral scan range was set at 45-450 (MHz).  
The chemical constituents were identified by GC-MS. The 
fragmentation patterns obtained from mass spectra were compared 
and analysed with spectrometer database using National Institute of 
Standards and Technology Mass Spectral database (NIST-MS). From 
the relative peak area of each component in the chromatogram the 
percentage of each component was calculated.  
 













1 14.43 Tetradecanoic acid C14H28O2 228 7.84 Antagonistic activity against Escherichia coli  
2 14.43 Octanoic acid C8H16O2 144 7.84 Prostaglandin E2 inhibitors, and Cox2  
3 14.43 Dodecanoic acid C12H24O2 200 7.84 Antimicrobial and anticancer activity  
4 14.43 D-Glucuronic acid C6H10O7 194 7.84 Apoptotic and cytotoxic activity 
5 14.43 Dodecanoic acid C12H24O2 200 7.84 Blood pressure regulation and vascular inflammation 
6 26.8 Trimethylsilyl C18H34O4Si3 398 4.21 Fungicidal activity  
7 26.8 Phenazine, 5,10-dioxide C12H8N2O2 212 4.21 Anti-trypanosomal activity  
8 28.8 Docosane C22H46 310 3.06 Antimicrobial activity  
9 28.8 Octadecane C18H38 254 3.06 Immuno-stimulating properties, Anti-inflammatory 
activity 
10 30.51 Benzoic acid C16H14O3 254 1.74 Drug metabolism in human liver  
11 30.51 Benzopyran-4-One C16H14O3 254 1.74 Antiestrogenic activity  
12 30.51 Fluoroquinazoline C15H11FN2O 254 1.74 Antifungal activity  
13 33.50 Phthalic acid C23H30O4 370 3.19 Insecticidal, Antibacterial, Gastroprotective and  
cytotoxic activity 
14 33.95 Diphenylpyridine C23H25N 315  3.98 Antiviral activity, Cytotoxicity 
15 33.95 Quinone C24H14O6 398  3.98 Biomarker for cancer chemoprevention 
16 34.28 Dimethylisoquinolin-8-ol C31H33NO4 483  4.94 Antibacterial activity and Cytotoxicity 
17 34.28 Tetramethyl C26H28O8 468  4.94 Antimalarial activity, cox2 inhibition 
18 34.28 Benzothiazin C11H13NOS 207  4.94 Antitubercular activity  
19 34.28 Morphinane C22H17F6N3O2 469  4.94 Cell protective activity  
20 35.09 Benzenepropanoic acid C11H14O3 194  2.73 Inhibitory activity against platelet aggregation  
21 35.09 Tetrafluoroborate C18H22BF4N2O4PS 480  2.73 Anti-hemolytic, Antibacterial activity  
22 35.93 Milbemycin B C32H44ClNO7 589  2.57 Insecticidal activity  
23 35.93 Carboxylate C17H23NO2 273  2.57 Neuropsychiatric events 
24 37.05 Propylamine C13H18FN 207  2.35 Cytotoxicity  
25 37.05 Enoic Acid C11H11FO2 194  2.35 Inhibitors of fatty acid and cyclooxygenase 
26 37.05 Butenoic acid C9H7BrO3 242  2.35 Antimicrobial, Effective dose to inhibit 
gastric acid secretion 
27 37.25 Pyridine C14H11N3O 253  2.20 Drug metabolism  
28 37.70 Methyl Ethyl Pyrazine C7H10N2 122  4.22 Cytoprotective activity  
29 37.70 Propenoate C9H11NO3 181  4.22 Antiapoptotic, Cardioprotective effect  
30 37.70 Pyrimidine C15H17FN2 244  4.22 Drug metabolism  
31 37.70 Glucopyranoside C33H55NO7 577  4.22 Inhibition of Saccharomyces  
32 38.21 Dichloro[tri(trimethylsilyl)
methyl]Silane 
C10H28Cl2Si4 330  1.90 Inhibit Cholesterol Biosynthesis, Cytotoxicity 
33 38.21 Diazepine C20H17N3O 315  1.90 Anticonvulsant activity  
34 38.43 Carboxylate C27H35NO6 469  1.88 Neuropsychiatric events 
35 38.43 Naphthalene C27H23N3O5 469  1.88 Inhibition of COX1  
36 38.43 Phenylimidazole C26H24N6OS 468 1.88 Cholesterol lowering effect 
37 38.43 Isophthalate C11H8F3IO7S 468 1.88 Cancer drug development 
38 38.43 Thiophene C29H24O2S2 468 1.88 Drug metabolism  
39 38.82 Quinazoline C19H13Br2N3 441  3.87 Antimicrobial activity  
40 39.17 Dihydrofuran C14H12O 196  1.87 Cytotoxicity Antibacterial activity  
41 39.92 Tetrahydroisoquinoline C17H20N2O2 284  2.45 Drug metabolism  
*Source of the Biological activities of the compound is PubChem database. 
 
Identification of compounds  
Using the database of National Institute Standard and Technology 
(NIST) having more than 62,000 patterns the interpretation of mass 
spectrum of GC-MS was conducted. The spectrum components of 
known compounds were compared with unknown components 
stored in the NIST library. The name, molecular weight and 
structure of the compounds were ascertained in above said way. 
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Identification of compounds having biological activity  
The obtained list of compounds was checked for having biological 
properties which are reported in PubChem. All the compounds 
which are subjected for Bioassay are listed in tables and 
phytochemicals having anti-inflammatory action is considered as 
positive hits for our study. 
RESULTS AND DISCUSSION  
Characterization of secondary metabolites from medicinal plants 
provides an extensive resource for the isolation and identification of 
novel therapeutic agents for inflammation. The major non-volatile 
compounds can be identified by GC-MS analysis. The crude 
methanolic extract revealed the high peak intensity compound 
predominant presence of major compounds like pentadecanoic acid, 
14-methyl-, methyl esters (RT-14.43) and methyl stearate among 
other derivatives. Minor compounds such as 10-methyl ester, methyl 
tetradecanoate, tetradecanoic acid, 12-methyl-methyl ester, 9-
hexadecenoic acid, hexadecanoic acid, 14-methyl-methyl ester, 10-
octadecenoic acid and heptadecanoic acid were also identified. 
These compounds are exhibited activities like antioxidant, cancer-
preventive, hypercholesterolemic, nematicide, antifungal and 
antimicrobial. The advantage of GC-MS is its highest accuracy in the 
identification of derivatized compounds. The list of compounds from 
different extracts and plant parts are as tabulated in table 1-4 and 
the respective spectrum is as shown in fig. 1-4. 
 










Area % Biological activity* 
1 13.90 Dimethylbenz Oate C14H20O4 252 0.33 Drug Metabolism and Pathologic Process  
2 13.90 Chloropyridine C11H8ClNO 205 0.33 Antinociceptive Activity  
3 13.90 Tetralone C13H16OS2 252 0.33 Parkinson's disease and depression 
4 13.90 Dihydroisobenzofuran C13H16O3 220 0.33 Drug-protein interactions at serotonin 
transporter 
5 13.90 Dicarboxylate C15H13ClO6 324 0.33 Agonist for metabotropic glutamate 
receptors 
6 13.90 Pyrazine C12H20N2Si 220 0.33 Antimalarial agent 
7 14.43 Acetamide C24H20BrN3O2S2 525  0.29 Radioligand for benzodiazepine receptor 
in brain 
8 14.43 Glaucine C21H25NO4 355 0.29 Antioxidant and Antiviral activity 
9 14.43 Quinoline C17H15Br2NO 455 0.29 Drug metabolism  
10 19.25 Carboxylate C13H18O5 254 0.37 Neuropsychiatric events in influenza  
11 19.25 Hexanoic acid C19H34N4O6 414 0.37 Inhibit cyclooxygenase activity 
12 23.00 Hexadecanoic acid C18H36O2 284 0.44 Promote cancer cell death 
13 24.92 Glucopyranose C15H19D3O10 362 0.34 Cytotoxicity  
14 24.92 Oxodehydroabietate C21H28O3 328 0.34 Cytotoxicity  
15 24.92 Cyclohexanol C13H24O2 212 0.34 MDR-reversal drug lead 
16 26.00 Bromobenzene C15H13BrO2S 336  0.44 Anticancer,  Antimicrobial Activity  
17 26.00 Cyclopropane C10H12S 164  0.44 Inhibition Assay  
18 28.33 Phthalimide C19H16ClNO2S 357  0.38 Hypolipidemic activity  
19 28.33 Colchicine C20H23NO5 357  0.38 Binding affinity  
20 28.33 Diphenylquinoline C22H17N 295 0.38 Metabolic stability  
21 28.77 Haliclonacyclamine  C32H58N2 470  0.54 Cytotoxicity  
22 29.42 Cyanopyridine C18H20N2 264  0.51 Antimicrobial activity  
23 29.42 Ethanone hydrochloride C6H11NOS2 177  0.51 Antiproliferative activity 
24 29.42 Oxazoline C21H25NO7 403  0.51 Ovicidal activity  
25 29.89 Pyridinedicarboxylic acid C21H27NO5 373  1.92 Inhibitory against Hepatitis B  
26 31.74 Stigmastane C29H52 400  0.29 Antimicrobial, Effective dose to inhibit 
gastric acid secretion 
27 31.74 Phenylquinoxaline C15H10ClN3O2 299  0.29 Binding affinity to beta-amyloid in 
Alzheimer's disease  
28 31.74 Glucopyranosiduronic acid C29H56N2O10S 676  0.29 Cytotoxicity  




C23H26O4S2 430  0.72 Analgesic activity  
30 32.86 Carbaldehyde C34H35N5O5 593  1.23 Inhibitory drugs for smoking reduction 
31 32.86 Oxazolidinone C20H27NO4S 377  1.23 Antimycobacterial activity  
32 32.86 Sanguinarine C22H19NO5 377  1.23 Antibacterial activity 
33 33.31 Oxazoline C21H25NO7 403  0.27 Ovicidal activity  
34 33.31 Tetrahydroisoquinolin-4-ol C19H20N2O6 372  0.27 Potentiating and inhibiting activity 
35 33.70 Imidazole C16H10Br2N2O 404  0.46 Kinase Assay  
36 33.70 Oxobutanoic acid C20H23FN2O5 390 0.46 Stimulated Gastric Acid Secretion  
37 34.23 Phenylindole C16H15NO2 253 1.29  Pro-apoptotic in cancer cells  
38 34.23 Azepine C14H14N2OSi 254 1.29 Antioxidant activity  
39 34.64 Acetohydrazide C24H30N2O6 442  1.08 Inhibition of topoisomerase 2  
40 34.64 Physodic acid C26H30O8 470  1.08 Drug metabolism  
41 39.16 ë(2,2')-Bis(1,3-dithio[4,5-
c]selenophene) 
C10H4S4Se2 412  69.34 Antimicrobial activity  
42 39.57 Quinolinecarboxylic acid C10H9NO4 207 3.56 Gastrointestinal disorder 
43 39.57 4-Methylthio-3-
quinolinesulfonamide 
C10H10N2O2S2 254 3.56 Antidepressant activity  
44 40.24 4H-1-Benzopyran-4-one C28H26O10 522 5.24 Potent anti-estrogens.  
45 40.42 N-Benzyl-2-Bromoaniline C13H12BrN 261 1.55 Inhibition of Fibroblast  
*Source of the Biological activities of the compound is PubChem database. 
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1 15.51 Monohydroxamic acid C8H7NO4 181 2.78 Inhibition Of Leukemia Cells  
2 15.51 Piperidine C11H24N2O 200 2.78 Potential cocaine antagonists. 
3 15.51 Serine C3H6DNO3 105 2.78 Inhibit, osteoarthritis, Alzheimer's, age-related macular 
degeneration 
4 16.84 Arsine, trimethyl-(CAS) C3H9As 120 1.24 Decreased heart uptake with alkyl substitution 
5 16.84 Pyridine C11H9NO2 187 1.24 Hypo-cholesteremic activity 
6 19.85 Propanone C24H51NO5Si5 573 1.11 Antagonist activity  
7 19.85 Quinazolin-8-one C20H20N2O5 368 1.11 Anti-inflammatory activity  
8 19.85 Trimethylsilyl ester C20H40O5Si4 472 1.11 Antiviral activity and Cytotoxicity 
9 21.77 Annulene C21H18 270 1.96 Cytotoxicity  
10 21.77 Anthraquinone C15H10O3S 270 1.96 Anti-filarial activity, Cytotoxicity 
11 21.77 Isoquinolin C28H21NO 387 1.96 Increase of intracellular drug uptake  
12 21.77 Azulene C20H14O 270 1.96 Agonist Activity  
13 22.03 Hexadecenoic acid C17H32O2 268 0.91 Antibacterial activity Anti-plasmodial activity 
14 22.03 Hydroxy palmitate C19H36O4 328 0.91 Antihyperglycemic activity  
15 22.87 Benzenedicarboxylic acid C16H22O4 278 1.09 Antitumor activity  
16 22.87 phenylpropionate C13H17ClO2 240 1.09 Cellular uptake in human PBMC nucleus  
17 22.87 Naphthalene C11H19NO3 213 1.09 Inhibition of HIV1 protease dimerization  
18 22.87 Phenylpropan-1-one C17H18O2 254 1.09 Bio-reduction by bacterial ferredoxin 
19 23.97 Methacrylate C21H32O3 332 0.86 Antiparasitic activity  
20 23.97 Butyl acrylate C21H32O3 332 0.86 Cytotoxicity Antioxidant activity 
21 23.97 1,3-Dithiolane  C19H30S2 322 0.86 Detoxification activity  
22 25.60 Octadecanoic acid C19H38O2 298 1.33 Highest toxicity against pathogens 
23 28.25 N-phenylnitrone C16H21NO3 275 1.43 Cytoprotective activity  
24 28.25 Carboxylic acid C13H17NO3 235 1.43 Anti-spermatogenic activity, Drug metabolism 
25 28.25 Oxoquinoline C12H12N2O4S2 312 1.43 Antimicrobial activity 
26 28.25 Methy L Dopamine C15H10Cl3F6N 503 1.43 Binding affinity towards human dopamine D4 receptor  
27 28.25 Glucopyranosiduronic acid C29H57NO8Si5 687 1.43 Inhibition of HIV1 protease  
28 28.25 Trimethylsilyl ester C29H57NO8Si5 687 1.43 Antiviral activity, Cytotoxicity 
29 28.88 Glutamic acid dimethyl 
ester 
C7H12DNO4 175 2.16 Inhibitory Activity Against Leukaemia Cells  
30 28.88 Dihydropyrrole C11H5F16N 455 2.16 Mitotic arrest of ovarian carcinoma cells 
31 29.73 Azetidinone C24H25NO6S 455 2.16 Reduction of liver cholesteryl esters 
32 29.73 Quinoxalinone C27H25N3O4 455 2.39 Cytotoxicity  
33 29.73 Methylphenol C26H35ClN4O 454 2.39 Antimicrobial activity  
34 29.73 Argentatin C33H54O4 514 2.39 Inhibitory towards leukemic cell line  
35 29.73 Isopropylamide C32H41NO 455 2.39 Inhibitor of beta-galactosidases. 
36 31.32 Montiporyne C15H20O 216 5.25 Cytotoxicity  
37 31.32 Chlorophenol C12H13ClO 208 5.25 Anti-trypanosomal activity  
38 31.32 Dimethylindole C10H10N2O3 206 5.25 Growth inhibitory activity against pancreatic cancer cells. 
39 31.32 Benzimidazole C11H13N3S 219 3.65 Reduced blood pressure  
40 31.32 Cyclopropane C20H18N2 286 3.65 Potential targets for anti-tuberculous drugs 
41 32.20 Aminocyclohexane C25H26BrN2O 512 0.82 Antidiuretic activity 
42 32.20 Dimethoxy indole C33H27N3O3 513 0.82 Antitumor activity  
43 32.20 Methylpyrazole C20H20Br2N2 510 0.82 Drug metabolism in human liver, osteoporosis 
44 32.93 Dimethylcoumarin C11H10O3 190 0.91 Inhibition of monoamine oxidases 
45 33.12 Lupeol C30H50O 426 6.50 Reduce blood glucose, Cytotoxicity 
46 33.12 Sclareol C20H36O2 308 6.50 Cytotoxicity, Induction of apoptosis 
47 33.12 Farnesyl bromide C15H25Br 284 6.50 Anti-plasmodial activity  
48 33.12 Geranylgeraniol C20H34O 290 6.50 Cytotoxicity  
49 33.42 Illudinic acid C15H18O4 262 7.32 Antimicrobial activity, antitumor activity 
50 34.36 Ilicic Acid C15H24O4 268 2.12 Anti-inflammatory activity  
51 35.05 Dicarboxylic acid 
dimethyl ester 
C27H32O5 436 10.51 Antagonist activity  
52 35.05 Phthalazin-1(2H)-one C20H19N5OS 377 10.51 Antibacterial activity  
53 35.89 Quinazolinone C27H22N4O3 450 2.01 Treatment for neurodegenerative disorders 
54 35.89 Dimethoxybenzene C17H29BrO3Si 388 2.01 Cross allergenicity 
55 35.89 Scopadulane C24H38O4 390 2.01 Cytotoxicity, Antiviral activity 
56 36.13 Methylcrinasiadine C15H11NO3 253 2.31 Cytotoxic alkaloid 
57 36.13 Methylpyrrole C13H19NO4 253 2.31 Antitumor Activity  
58 36.84 Undecanolide C12H20O3 212 1.57 Antimicrobial activity, Cell cycle arrest in HepG2 cells 
59 36.84 Galactitol C18H26O12 434 1.57 Antihyperglycemic agent 
60 37.56 Aminodiphenylmethane C22H21NO2 331 0.98 Antimicrobial activity, Antiviral activity 
61 37.8 Propargyl ether C14H20O2S 252 1.21 Antinociceptive tests 
62 37.8 Phthalic acid C22H26O4 354 1.21 Insecticidal activity  
63 38.41 Porphine C36H42N4O4 594 10.21 Cytotoxicity  
64 38.78 Glucopyranosiduronic acid C27H52N2O10S 648 12.27 Cytotoxic activity, Anti-HIV-1 protease 
65 38.78 Hydroxypregnenolone C23H36O3 360 12.27 Steroid-producing neurons 
66 40.33 Azaanthracene C34H24N6 516 1.91 Activity against L1210 leukaemia cells  
*Source of the Biological activities of the compound is PubChem database. 
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1 15.51 Dihydroisocoumarin C13H16O2 204 2.73 Aromatase inhibitor 
2 16.84 Tert-butyldimethylsilyl ether C14H28O5Si 304 3.19 Antiviral activity, Cytotoxicity 
3 19.44 Iminoisoquinoline C11H12N2 172 1.32 Inhibitors of nitric oxide synthase 
4 19.44 Hydroxypropanoate C11H22O3 202 1.32 Antioxidant activity  
5 21.79 Hexadecanoic acid C17H34O2 270 3.12 Anticancer drug target 
6 21.79 Pentadecanoic acid C17H34O2 270 3.12 Inhibition of COX1 and prostaglandin biosynthesis 
7 24.76 Oxaspiro C14H20O3 236 1.26 Acts against cancer and inflammation 
8 25.72 Trimethylsilyl ester C20H40O5Si4 404 2.22 Anti-HIV activity 
9 26.80 D-glucopyranose C8H19ClO6 246 1.73 Cytotoxicity  
10 26.80 Octadecanoic acid C20H40O2 312 1.73 Antimicrobial agent 
11 27.94 Sulfoximine C23H31NO4S2 449 1.21 Cytotoxicity  
12 29.45 Benzeneacetic acid C10H12O3 180 1.60 Anti-inflammatory activity  
13 29.92 Cyanoacetate C20H15N3O5 377 1.63 Cytotoxicity, Antimicrobial activity 
14 29.92 Phenylmethanone C27H23NO 377 1.63 Inhibitory Activity on diabetes mellitus 
15 30.36 Ethanamine C9H13N 135 2.78 Antifungal activity  
16 30.36 2-(Chlorovinyl)phenyl sulfide C8H7ClS 170 2.78 Antimalarial design 
17 30.36 Dihydrobenzothiophene C15H14S 226 2.78 Potential treatment of Parkinson's disease 
18 30.36 Phenylpropan-1-one C17H18O2 254 1.09 Bioreduction by bacterial ferredoxin 
19 31.44 Tetraol C27H44O4 432 20.55 Cytotoxicity  
20 31.44 ç-Sitosterol C29H50O 414 20.55 Antiproliferative activity  
21 32.20 Cycloheptatrien C10H12O2 164 2.44 Neuroprotective activity  
22 32.52 Isopropylidene C39H50O4Si2 638 3.17 Antitumor and antiviral activity 
23 33.12 D-Glucopyranosiduronic acid C29H56N2O10S 676 2.42 Cytotoxicity  
24 33.12 Oxo-acetamide C24H23N3O3 401 2.42 Highly potent histone deacetylase inhibitors 
25 33.79 Azabicyclo C14H22N2 218 1.79 Muscarinic receptor antagonists 
26 33.79 Quinazolinone C19H23N3O2 325 1.79 Neurodegenerative disorder 
27 34.17 Glucopyranosiduronic acid C29H57NO8Si5 687 1.43 Inhibition of HIV1 protease  
28 34.17 Porphycene C31H36N4O4 528 1.24 Induction of apoptosis in human HeLa  
29 34.17 Spongiadioxin C13H6Br4O3 526 1.24 Cytotoxicity  
30 34.48 Oxazolidinone C12H15NO5 253 1.42 Antibacterial activity  
31 34.48 Cinnamate C19H18O3S 326 1.42 Depigmenting activity  
32 34.48 Dimethyluracil C15H22N2O6 326 1.42 Antibacterial activity  
33 36.46 Propylpyrimidine C28H28N2O3 440 16.55 Binding affinity towards Corticotropin  
34 37.46 Androstane C21H34N2O2 346 2.16  Inhibition of reduction of dihydrotestosterone 
35 38.66 Trifluoromethanesulfonate C9H9F3O5S 286 1.44 Antineoplastic activity  
36 38.66 Benzenecarboximidamide C15H12F3N3O3 339 1.44 Antithrombotic 
37 38.92 Norsesterterpene C24H38O2 358 1.62 Cytotoxicity  
38 38.92 Methyl pentyl ester C20H27ClO4 366 1.62 Antiviral agent 
39 39.72 Hydroxycodeinone C18H19NO4 313 3.97 Antagonistic Activity  
40 39.72 Pyrimidine C22H22N2 314 3.97 Drug metabolism  
41 39.72 Phenanthroline C19H11N3O2 313 3.97 Cytotoxicity 
42 39.72 Indolizine C21H15NO2 313 3.97 Inhibition of human EGFR autophosphorylation  
43 39.72 Nitroanthracene C19H23NO3 313 3.97 Cancer therapy 
44 40.02 Norbornadiene C14H13N 195 1.82 Analgesic activity, Psychotomimetic activity 
45 40.27 Phenanthrene C28H20Br2 514 1.65 Antiviral activity, Drug metabolism 
46 40.27 Gomisin F C28H34O9 514 1.65 Cytotoxicity, Antiviral activity 
*Source of the Biological activities of the compound is PubChem database. 
 
 
Fig. 1: Showing the GC-MS spectrum of Trichosanthes lobata leaf extracted from Ethyl acetate 
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Fig. 2: Showing the GC-MS spectrum of Trichosanthes lobata stem extracted from Ethyl acetate 
 
 
Fig. 3: Showing the GC-MS spectrum of Trichosanthes lobata leaf extracted from Methanol 
 
 
Fig. 4: Showing the GC-MS spectrum of Trichosanthes lobata stem extracted from Methanol 
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The GC-MS profile of Ethyl acetate leaf extract of Trichosanthes 
lobata showed the presence of 41 bioactive compounds, whereas its 
stem extract showed 45 compounds which are reported for various 
bioassays in PubChem. The GC-MS profile of methanol leaf extract of 
T. lobata showed 66 compounds which are biologically active and its 
respective stem extract contained 46 compounds having bioassay 
reports in PubChem. Overall, a large number of phytochemical 
compounds with good area percentage were found in methanolic 
extract, which was followed by ethyl acetate. We could also note that 
the number of active compounds was found more in leaf than in 
stem extracts. We were also able to find out potent anti-
inflammatory compounds such as Octanoic acid, Dodecanoic acid, 
Octadecane, Tetramethyl, Enoic acid and Napthalene from ethyl 
acetate leaf extracts; Hexanoic acid and Methyl propyl from ethyl 
acetate stem extracts. Similarly, anti-inflammatory compounds such 
as Methylpyrazole, Quinazolin-8-one and Ilicic acid were present in 
the methanol leaf extract, whereas Pentadecanoic acid, Oxaspiro, 
Benzeneacetic acid and Norbornadiene were present in the 
methanol stem extract. With this we conclude that a greater number 
of bioactive agents against inflammation is found in extracts of leaf 
generated using ethyl acetate.  
Many studies have proven that methanol has higher activities than 
that of extracts obtained from different solvents. In this case also 
even though methanolic extract has shown the presence of more 
number compounds, ethyl acetate leaf extracts stand to be effective 
against treating inflammation. Based on these examinations the anti-
inflammatory activity of ethyl acetate and methanol leaf extracts 
may be attributed towards the presence of very active agents. The 
thorough quantitative analysis of phytochemicals using GC-MS 
studies reveals the presence of all components such as flavonoids, 
sterols, fatty acid and esters in the sample [5]. GC-MS analysis is also 
helpful in the determination of the chemical composition, area and 
molecular weight of the samples [6, 7]. 
In addition to anti-inflammatory activity we could notice that the 
extracts contain compounds which are responsible for treating other 
ailments too. It is reported that T. lobata, T. dioica [8, 9] T. 
cucumerina [10, 11] and T. kirilowii are said to contain 
carbohydrates, glycosides, flavonoids, tannins, proteins, steroids and 
saponins. T. lobata is used for malarial fever and liver disorders [12]. 
The highlighted compounds had been noted earlier for their anti-
inflammatory potential. Active polyphenols, flavones, phenolic 
terpenes, fatty acids, sterols, amide, esters, alkaloids, flavonoids, 
lactones and carotenoids such as Orientin, isoorientin, isovitexin, 
vitexin, chlorogenic acid, catechin, palmitic, stearic, vanillic acids, 
sitotesnone, vinyl guaiacol, o-Tolylaldehyde, epicatechin, 
procyanidins, protocatechuic acid, oleanolic acids, Pomolic acid, α-
amyrin, β-amyrin and derivatives of stigmasterol, oleic, linoleic, 
linolenic, limonene, lupeol, phytol, vellaral, cucuminoids, selinene, 
piperitol, camphor, quercetin, kaempferol, benzoazolinone, 
tocopherol, eugenol, myricetin, thymol, lutein, carotene, etc. have 
been proven for their anti-inflammatory potential in varied plant 
species [13-15]. More number of compounds present in the list are 
attributed towards cytotoxic activity and hence Trichosanthes lobata 
can be a potent anti-cancer agent also. 
CONCLUSION 
The analytical characterization of ethyl acetate and methanol extract 
of Trichosanthes lobata leaf and stem witness the presence of active 
metabolites. GC-MS reveals that the plant and its extract has valued 
agents which fulfil the pharmaceutical need. From the present study, 
it is confirmed that Trichosanthes lobata ethyl acetate and methanol 
leaf extract can be used as potent anti-inflammatory drug. Further, 
the fractions containing active compounds should be isolated from 
the extract and has to be examined through in vivo experiments. This 
will confirm their mechanism of action as novel therapeutic agent 
against inflammation. This research article also emphasizes varied 
pharmacological properties of Trichosanthes lobata in treating 
various disorders like cancer, neurological disorder, aging, against 




Both the authors of the research article have sufficiently participated 
in the intellectual content, conception, design, analysis, 
interpretation of data and writing the manuscript.  
CONFLICT OF INTERESTS 
There remains no conflict of interest. 
REFERENCES 
1. Chin YW, Balunas MJ, Chai HB, Kinghorn AD. Drug discovery 
from natural sources. Am Assoc Pharm Sci J 2006;8:239-53. 
2. Pangestuti R, Kim SK. Biological activities and health benefit 
effects of natural pigments derived from marine algae. J 
Functional Foods 2011;3:255-66. 
3. Chippada SC, Volluri SS, Bammidi S, Vangalapati M. In vitro 
anti-inflammatory activity of methanolic extract of Centella 
asiatica by HRBC membrane stabilization. Rasayan J Chem 
2011;4:457-60. 
4. Fulzule SV, Satturwar D, Joshi SB. Studies on anti-inflammatory 
activity of a poly herbal formulation-JatydiGhrita. Indian Drugs 
2001;39:785-7. 
5. Wang S, Karthickeyan V, Sivakumar E, Lakshmikandan M. 
Experimental investigation on pumpkin seed oil methyl ester 
blend in diesel engine with various injection pressure, injection 
timing and compression ratio. Fuel 2020;264:1-15. 
6. Ishtiaq S, Hanif U, Shaheen S, Bahadur S, Liaqat I, Awan UF, et 
al. Antioxidant potential and chemical characterization of 
bioactive compounds from a medicinal plant Colebrokea 
oppositifolia Sm. An Acad Bras Cienc 2020;92:1-15. 
7. Rubab S, Rizwani GH, Bahadur S, Shah M, Alsamadany H, 
Alzahrani Y, et al. Neuropharmacological potential of various 
morphological parts of Camellia sinensis L. Saudi J Biol Sci 
2020;27:567–73. 
8. Bhattacharya S, Kanti Halder P. Antibacterial activity of 
Trichosanthes diocia root. Global J Pharmacol 2010;4:122-6. 
9. Badrul Alam M, Sarowar Hossain M, Sultana Chowdary N, 
Asadujjaman M, Ronok Zahan, Monirul Islam M, et al. Antioxidant, 
anti-inflammatory and anti-pyretic activities of Trichosanthes 
diocia Roxb. fruits. J Pharmacol Toxicol 2011;6:440-53.  
10. Kolte RM, Bisan VV, Jangde CR, Bhalerao AA. Anti-inflammatory 
activity of root tubers of Trichosanthes cucumerina in mouse’s 
hind paw oedema induced by carrageenin. Indian J Indigenous 
Med 1997;18:117-21. 
11. Kongtun S, Jiratchariyakul W, Mongkarndi P, Theppeang K, 
Sethajintanin I, Jaridasem S, et al. Cytotoxic properties of root 
extract and fruit juice of Tricosanthes cucumerina. J 
Phytopharm 1999;6:1-9. 
12. Karuppusamy S. Medicinal plants used by paliyan tribes of 
sirumalai hills of South India. Nat Prod Rad 2007;6:436-42. 
13. Poletto P, Alvarez Rivera G, Torres TMS, Mendiola JA, Ibanez E, 
Cifuentes A. Review: compressed fluids and phytochemical 
profiling tools to obtain and characterize antiviral and anti-
inflammatory compounds from natural sources. Trend Anal 
Chem 2020;129:115942. 
14. Maiara Aline Daga, Thais Soprani Ayala, Rafael Andrade 
Menolli. A review of the anti-inflammatory and antimicrobial 
activities of the components of the Cecropia genus. Asian J 
Pharm Clin Res 2020;3:13-20. 
15. Clara dos Reis Nunes, Mariana Barreto Arantes, Silvia Menezes 
de Faria Pereira, Larissa Leandro da Cruz, Michel de Souza 
Passos, Luana Pereira de Moraes, et al. Plants as sources of 
anti-inflammatory agents. Molecules 2020;25:1-22. 
 
